Dr. Andrew Feranchak and colleagues published an article in Hepatology, entitled, “Identification of the chloride channel, leucine-rich repeat-containing protein 8, subfamily a (LRRC8A), in mouse cholangiocytes.”
Shcheynikov N, Boggs K, Green A, Feranchak AP. Identification of the chloride channel, leucine-rich repeat-containing protein 8, subfamily a (LRRC8A), in mouse cholangiocytes. Hepatology. 2022 Apr 21. doi: 10.1002/hep.32536. Epub ahead of print. PMID: 35445421.
Drew Feranchak, MD


Background and aims: Chloride (Cl ) channels in the apical membrane of biliary epithelial cells (BECs), also known as cholangiocytes, provide the driving force for biliary secretion. Although two Cl channels have been identified on a molecular basis, the Cystic Fibrosis Transmembrane Conductance Regulator and Transmembrane Member 16A, a third Cl channel with unique biophysical properties has been described. Leucine-Rich Repeat-Containing Protein 8, subfamily A (LRRC8A) is a newly identified protein capable of transporting Cl in other epithelium in response to cell swelling. The aim of the present study was to determine if LRRC8A represents the volume-regulated anion channel in mouse BECs.

Approach and results: Studies were performed in mouse small (MSC) and large (MLC) cholangiocytes. Membrane Cl currents were measured by whole-cell patch-clamp techniques and cell volume measurements were performed by calcein-AM fluorescence. Exposure of either MSC or MLC to hypotonicity (190 mOsm) rapidly increased cell volume and activated Cl currents. Currents exhibited outward rectification, time-dependent inactivation at positive membrane potentials, and reversal potential at 0 mV (ECl ). Removal of extracellular Cl or specific pharmacological inhibition of LRRC8A abolished currents. LRRC8A was detected in both MSC and MLC by reverse transcription polymerase chain reaction and confirmed by western blot. Transfection with LRRC8A small interfering RNA decreased protein levels by >70% and abolished volume-stimulated Cl currents.

Conclusion: These results demonstrate that LRRC8A is functionally present in mouse BECs, contributes to volume-activated Cl secretion, and, therefore, may be a target to modulate bile formation in the treatment of cholestatic liver disorders.